156 companies
Travere Therapeutics
Market Cap: US$4.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$45.81
7D
1.7%
1Y
207.2%
Madrigal Pharmaceuticals
Market Cap: US$11.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$486.98
7D
1.2%
1Y
73.8%
Lumentum Holdings
Market Cap: US$67.2b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$863.66
7D
-4.6%
1Y
951.8%
Infinity Natural Resources
Market Cap: US$836.1m
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$13.16
7D
-0.8%
1Y
-21.4%
Zevra Therapeutics
Market Cap: US$627.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$10.61
7D
-7.7%
1Y
15.5%
Syndax Pharmaceuticals
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$17.34
7D
-8.0%
1Y
56.4%
AppLovin
Market Cap: US$187.2b
Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.
APP
US$557.20
7D
-9.2%
1Y
45.3%
Broadcom
Market Cap: US$1.8t
Designs, develops, and supplies various semiconductor devices and infrastructure software solutions internationally.
AVGO
US$385.73
7D
-16.1%
1Y
57.9%
PicS
Market Cap: US$1.2b
Operates as a digital financial services company that provides digital wallet and application for individuals and businesses in Brazil.
PICS
US$9.18
7D
-17.1%
1Y
n/a
AnaptysBio
Market Cap: US$1.5b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$50.37
7D
-5.2%
1Y
117.2%
Ardelyx
Market Cap: US$1.4b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.56
7D
-3.0%
1Y
47.9%
AGI
Market Cap: US$1.1b
Provides technology-powered specialized financial services in Brazil.
AGBK
US$6.71
7D
-8.1%
1Y
n/a
Alignment Healthcare
Market Cap: US$3.2b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$15.37
7D
15.6%
1Y
4.0%
WaterBridge Infrastructure
Market Cap: US$3.6b
WaterBridge Infrastructure LLC, water infrastructure company, provides water management solutions through integrated pipeline and water handling networks in the United States.
WBI
US$29.44
7D
1.7%
1Y
n/a
Oracle
Market Cap: US$614.6b
Offers products and services that address enterprise information technology environments worldwide.
ORCL
US$213.68
7D
-13.9%
1Y
20.6%
National Energy Services Reunited
Market Cap: US$2.4b
Provides oilfield services in the Middle East and North Africa.
NESR
US$23.90
7D
-2.0%
1Y
291.2%
FTAI Aviation
Market Cap: US$24.0b
Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.
FTAI
US$234.05
7D
-5.6%
1Y
87.6%
Luckin Coffee
Market Cap: US$10.4b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$32.12
7D
-1.2%
1Y
-10.7%
Abeona Therapeutics
Market Cap: US$311.2m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.46
7D
-3.0%
1Y
-16.5%
Pagaya Technologies
Market Cap: US$1.2b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$14.56
7D
-6.9%
1Y
-15.9%
Zscaler
Market Cap: US$21.1b
Operates as a cloud security company worldwide.
ZS
US$130.78
7D
-16.0%
1Y
-56.4%
McEwen
Market Cap: US$1.1b
Engages in the exploration, development, production, and sale of gold and silver deposits in the United States, Canada, Mexico, and Argentina.
MUX
US$18.28
7D
-16.0%
1Y
92.0%
UroGen Pharma
Market Cap: US$1.3b
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$26.85
7D
-0.7%
1Y
282.5%
Compass
Market Cap: US$5.8b
Provides an end-to-end technology platform for residential real estate in the United States.
COMP
US$7.71
7D
-8.8%
1Y
25.2%
FirstSun Capital Bancorp
Market Cap: US$1.7b
Operates as the bank holding company for Sunflower Bank, National Association that provides commercial and consumer banking and financial services to small and medium-sized companies in the United States.
FSUN
US$35.67
7D
2.6%
1Y
1.9%
Pelthos Therapeutics
Market Cap: US$88.8m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$25.55
7D
-2.5%
1Y
111.2%
ARS Pharmaceuticals
Market Cap: US$850.0m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$8.56
7D
-9.2%
1Y
-41.1%
AVITA Medical
Market Cap: US$128.6m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$4.18
7D
-4.6%
1Y
-31.6%
Capricor Therapeutics
Market Cap: US$1.5b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$26.71
7D
-6.4%
1Y
99.6%
Aldeyra Therapeutics
Market Cap: US$98.3m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.63
7D
-1.8%
1Y
-39.0%
Columbus McKinnon
Market Cap: US$366.0m
Designs, manufactures, and markets motion solutions for moving, lifting, positioning, and securing materials worldwide.
CMCO
US$12.88
7D
-17.3%
1Y
-20.2%
Simmons First National
Market Cap: US$3.1b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$21.58
7D
2.5%
1Y
13.7%
Ascendis Pharma
Market Cap: US$13.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$210.45
7D
-3.8%
1Y
n/a
CG Oncology
Market Cap: US$4.7b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$53.72
7D
-9.3%
1Y
99.0%
Gossamer Bio
Market Cap: US$41.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
GOSS
US$0.17
7D
-11.7%
1Y
-86.8%
Atlassian
Market Cap: US$25.2b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$99.47
7D
-14.2%
1Y
-53.7%